New heart drug UDP-003 enters first human safety tests
Disease control
Recruiting now
This early-stage trial tests whether an experimental drug called UDP-003 is safe in healthy volunteers and people with heart disease. Researchers will give single or multiple doses of the drug or a placebo and monitor for side effects. The study includes 84 participants and is th…
Phase: EARLY_PHASE1 • Sponsor: Cyclarity Therapeutics, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC